GINGEMBRE

Food supplement declared in France, declaration No 2017-11-855, decision dated 24 November 2017

GINGEMBRE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand: not provided
Food business operator placing the product on the market: SAS S.I.D. NUTRITION
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: 2 gélules
Directions for use: 1 à 2 gélules par jour à avaler avec un grand verre d'eau, idéalement 30 minutes avant le départ
Intended populations: Homme, Femme
Not recommended for (according to the manufacturer): Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims): Digestion

Declaration 205712, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

Plant	Part	Preparation	Per day
Zingiber officinale Roscoe	Rhizome	Extrait sec hydroalcoolique	300 mg

Additives

E460, E967, E904, E1201

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated 24 November 2017 (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.